Study Of Celecoxib Or Diclofenac And Omeprazole For Gastrointestinal (GI) Safety In High GI Risk Patients With Arthritis

NCT00141102 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

4484

Enrollment

INDUSTRY

Sponsor class

Conditions

Osteoarthritis
Arthritis, Rheumatoid

Interventions

DRUG: Celecoxib
DRUG: Diclofenac + Omeprazole

Sponsor

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.